BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 29554495)

  • 21. Combining therapeutic vaccines with chemo- and immunotherapies in the treatment of cancer.
    Kerr MD; McBride DA; Chumber AK; Shah NJ
    Expert Opin Drug Discov; 2021 Jan; 16(1):89-99. PubMed ID: 32867561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic Cell-Based Cancer Vaccines.
    Santos PM; Butterfield LH
    J Immunol; 2018 Jan; 200(2):443-449. PubMed ID: 29311386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Tumor Antigens and Cancer Immunotherapy.
    Vigneron N
    Biomed Res Int; 2015; 2015():948501. PubMed ID: 26161423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses.
    Vermaelen K
    Front Immunol; 2019; 10():8. PubMed ID: 30723469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in Vaccine Therapies for Breast Cancer.
    Li X; Bu X
    Adv Exp Med Biol; 2017; 1026():315-330. PubMed ID: 29282691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel era of cancer/testis antigen in cancer immunotherapy.
    Meng X; Sun X; Liu Z; He Y
    Int Immunopharmacol; 2021 Sep; 98():107889. PubMed ID: 34174699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-13 receptor-directed cancer vaccines and immunotherapy.
    Nakashima H; Husain SR; Puri RK
    Immunotherapy; 2012 Apr; 4(4):443-51. PubMed ID: 22512637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells.
    Ramachandran M; Dimberg A; Essand M
    Semin Cancer Biol; 2017 Aug; 45():23-35. PubMed ID: 28257957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide-based vaccines for cancer therapy.
    Parmiani G; Russo V; Maccalli C; Parolini D; Rizzo N; Maio M
    Hum Vaccin Immunother; 2014; 10(11):3175-8. PubMed ID: 25483658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
    H Yi D; Appel S
    Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities.
    Shemesh CS; Hsu JC; Hosseini I; Shen BQ; Rotte A; Twomey P; Girish S; Wu B
    Mol Ther; 2021 Feb; 29(2):555-570. PubMed ID: 33038322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA vaccine for cancer immunotherapy.
    Yang B; Jeang J; Yang A; Wu TC; Hung CF
    Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.
    Bol KF; Schreibelt G; Gerritsen WR; de Vries IJ; Figdor CG
    Clin Cancer Res; 2016 Apr; 22(8):1897-906. PubMed ID: 27084743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress and prospects in vaccine therapy for gynecologic cancers.
    Gurski KJ; Steller MA
    Oncology (Williston Park); 1997 Nov; 11(11):1727-34, 1739-40; discussion 1740,. PubMed ID: 9394368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Discovery of the splicing of peptides by the proteasome and study of preclinical models of anticancer immunotherapy].
    Van den Eynde B
    Bull Mem Acad R Med Belg; 2007; 162(5-6):352-6. PubMed ID: 18405005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell epitope peptide vaccines.
    Elsawa SF; Rodeberg DA; Celis E
    Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer immunotherapy: moving forward with peptide T cell vaccines.
    Kumai T; Fan A; Harabuchi Y; Celis E
    Curr Opin Immunol; 2017 Aug; 47():57-63. PubMed ID: 28734176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines.
    Grau M; Walker PR; Derouazi M
    Cell Mol Life Sci; 2018 Aug; 75(16):2887-2896. PubMed ID: 29508006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tumor vaccines-therapeutic vaccination against cancer].
    Rammensee HG; Löffler MW; Walz JS; Bokemeyer C; Haen SP; Gouttefangeas C
    Internist (Berl); 2020 Jul; 61(7):690-698. PubMed ID: 32462251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
    Jäger E; Jäger D; Knuth A
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.